Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis

PaperCitations, authors & open-access status

Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 29 citations, 2020 year and closed oa status.

29
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Praneeth Kudaravalli
Author
Digestive Diseases and Sciences
Journal
Inflammatory Bowel Disease
Topic
Inflammatory Bowel Disease
Topic
Rheumatoid Arthritis Research and Therapies
Topic
Biosimilars and Bioanalytical Methods
Topic
470M+ articles · free account